2-phenyl-2H-1,2,3,4-tetrazole-5-carboxylic acid → HCID 86688269, 화합물
반응식
[C:1]1([N:7]2[N:11]=[N:10][C:9]([C:12]([OH:14])=O)=[N:8]2)[CH:6]=[CH:5][CH:4]=[CH:3][CH:2]=1.C(OC([N:22]1[CH2:27][CH2:26][NH:25][C:24]([CH3:29])([CH3:28])[CH2:23]1)=O)(C)(C)C.[F:30][C:31]([F:36])([F:35])[C:32]([OH:34])=[O:33].CC1(C)CNCCN1C(C1N=CN(C2C=CC=CC=2)N=1)=O>>[F:30][C:31]([F:36])([F:35])[C:32]([OH:34])=[O:33].[CH3:28][C:24]1([CH3:29])[CH2:23][NH:22][CH2:27][CH2:26][N:25]1[C:12]([C:9]1[N:10]=[N:11][N:7]([C:1]2[CH:2]=[CH:3][CH:4]=[CH:5][CH:6]=2)[N:8]=1)=[O:14]참가 물질
4
실험 절차
This intermediate was prepared from 2-phenyl-2H-tetrazole-5-carboxylic acid and 3,3-dimethyl-piperazine-1-carboxylic acid tert-butyl ester in two steps according to the preparation of (2,2-dimethyl-piperazin-1-yl)-(1-phenyl-1-H-[1,2,4]-triazol-3-yl)-methanone trifluoroacetate.